This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations in Oncolytic Virus Production by Markus Riese
Introduction
Markus Riese is a notable inventor based in Munich, Germany. He has made significant contributions to the field of virology, particularly in the production and purification of oncolytic viruses. His work focuses on enhancing the efficacy and scalability of viral therapies for clinical applications.
Latest Patents
Markus Riese holds a patent for a "Scalable process for oncolytic rat parvovirus H-1 production and purification based on isoelectric point-based elimination of empty particles." This invention provides a reproducible, effective, and scalable process for the purification of infectious parvovirus H-1 particles. The purification process allows for the separation of empty particles from those containing a full genome, making it compatible with large-scale H-1PV production for clinical applications.
Career Highlights
Riese is affiliated with the Deutsches Krebsforschungszentrum, where he continues to advance research in cancer therapies. His innovative approaches have positioned him as a key figure in the development of oncolytic virus treatments.
Collaborations
Some of his notable coworkers include Barbara Leuchs and Jean Rommelaere, who have collaborated with him on various research projects.
Conclusion
Markus Riese's contributions to the field of oncolytic virus production are paving the way for more effective cancer treatments. His innovative patent demonstrates the potential for scalable viral therapies in clinical settings.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile